FDA-Nixed Language Can Be In Drug Promos, Expert Testifies

Law360 (July 19, 2021, 9:29 PM EDT) -- A former FDA official testified in a California opioid trial Monday that it would not necessarily be a problem if drugmaker Endo's promotional material included a phrase that regulators had demanded be taken out of the product's official label.

Minnie Baylor-Henry, the director from 1995 to 1999 of the U.S. Food and Drug Administration's Division of Drug Marketing, Advertising, and Communications — or DDMAC — spent nearly a day on the stand as an expert witness for Endo, one of the drugmakers defending against four California jurisdictions' claims that they ushered addictive drugs into the health care ecosystem and created a...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!